NO983449L - Varianter av thymidinkinase, tilsvarende nukleinsyresekvenser og deres anvendelse ved genterapi - Google Patents

Varianter av thymidinkinase, tilsvarende nukleinsyresekvenser og deres anvendelse ved genterapi

Info

Publication number
NO983449L
NO983449L NO983449A NO983449A NO983449L NO 983449 L NO983449 L NO 983449L NO 983449 A NO983449 A NO 983449A NO 983449 A NO983449 A NO 983449A NO 983449 L NO983449 L NO 983449L
Authority
NO
Norway
Prior art keywords
variants
nucleic acid
acid sequences
gene therapy
thymidine kinase
Prior art date
Application number
NO983449A
Other languages
English (en)
Other versions
NO983449D0 (no
Inventor
Joul Crouzet
Francis Blanche
Michel Couder
Beatrice Cameron
Original Assignee
Rh Ne Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9601603A external-priority patent/FR2744731B1/fr
Priority claimed from FR9609709A external-priority patent/FR2751988B1/fr
Application filed by Rh Ne Poulenc Rorer Sa filed Critical Rh Ne Poulenc Rorer Sa
Publication of NO983449D0 publication Critical patent/NO983449D0/no
Publication of NO983449L publication Critical patent/NO983449L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO983449A 1996-02-09 1998-07-27 Varianter av thymidinkinase, tilsvarende nukleinsyresekvenser og deres anvendelse ved genterapi NO983449L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9601603A FR2744731B1 (fr) 1996-02-09 1996-02-09 Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
FR9609709A FR2751988B1 (fr) 1996-08-01 1996-08-01 Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
PCT/FR1997/000193 WO1997029196A1 (fr) 1996-02-09 1997-01-31 Variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique

Publications (2)

Publication Number Publication Date
NO983449D0 NO983449D0 (no) 1998-07-27
NO983449L true NO983449L (no) 1998-07-27

Family

ID=26232518

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983449A NO983449L (no) 1996-02-09 1998-07-27 Varianter av thymidinkinase, tilsvarende nukleinsyresekvenser og deres anvendelse ved genterapi

Country Status (12)

Country Link
US (2) US6207150B1 (no)
EP (1) EP0879288A1 (no)
JP (1) JP2000505288A (no)
KR (1) KR19990082124A (no)
AU (1) AU720936B2 (no)
BR (1) BR9707483A (no)
CZ (1) CZ294497B6 (no)
HU (1) HUP9902571A3 (no)
IL (1) IL125597A0 (no)
NO (1) NO983449L (no)
SK (1) SK107998A3 (no)
WO (1) WO1997029196A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451571B1 (en) 1994-05-02 2002-09-17 University Of Washington Thymidine kinase mutants
EP1914304A1 (en) * 1998-10-14 2008-04-23 Darwin Molecular Corporation Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
EP2386629A1 (en) 1997-10-14 2011-11-16 Darwin Molecular Corporation Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
CN1301821A (zh) * 1999-12-27 2001-07-04 上海博德基因开发有限公司 一种新的多肽——胸腺嘧啶核苷酸激酶11和编码这种多肽的多核苷酸
GB0008966D0 (en) * 2000-04-13 2000-05-31 Imp College Innovations Ltd Vectors for gene therapy
US20040072168A1 (en) * 2000-05-12 2004-04-15 Wolfgang Knecht Novel deoxynucleoside kinase enzyme variants
FR2823219B1 (fr) * 2001-04-10 2003-07-04 Pasteur Institut Mutants de la desoxycytidine kinase possedant une activite enzymatique elargie
US20040053836A1 (en) * 2002-04-22 2004-03-18 Philipp Mayer-Kuckuk Method for modulating the production of a selected protein in vivo
US20070167353A1 (en) * 2003-10-24 2007-07-19 John Hilfinger Prodrug composition
US20050137141A1 (en) * 2003-10-24 2005-06-23 John Hilfinger Prodrug composition
GB0413702D0 (en) * 2004-06-18 2004-07-21 Molmed Spa Thymidine kinase
JP5567016B2 (ja) 2008-08-15 2014-08-06 ザ ユーエイビー リサーチ ファンデイション ヌクレアーゼプロドラッグの酵素アクチベーターとしてのプリンヌクレオシドホスホリラーゼ
US20110023150A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genome editing of genes associated with schizophrenia in animals
US20110023139A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in cardiovascular disease
US20110016541A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genome editing of sensory-related genes in animals
US20110023144A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in amyotrophyic lateral sclerosis disease
US20110023147A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of prion disorder-related genes in animals
US20110023158A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Bovine genome editing with zinc finger nucleases
US20110023145A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in autism spectrum disorders
US20110023149A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in tumor suppression in animals
US20110030072A1 (en) * 2008-12-04 2011-02-03 Sigma-Aldrich Co. Genome editing of immunodeficiency genes in animals
US20110023154A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Silkworm genome editing with zinc finger nucleases
US20110023146A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in secretase-associated disorders
US20110023148A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genome editing of addiction-related genes in animals
US20110023141A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved with parkinson's disease
US20110016539A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genome editing of neurotransmission-related genes in animals
US20110023151A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genome editing of abc transporters
US20110023140A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Rabbit genome editing with zinc finger nucleases
US20110016540A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genome editing of genes associated with trinucleotide repeat expansion disorders in animals
US20110016543A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genomic editing of genes involved in inflammation
US20110023143A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of neurodevelopmental genes in animals
US20110023153A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in alzheimer's disease
US20110023156A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Feline genome editing with zinc finger nucleases
US20110023152A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genome editing of cognition related genes in animals
US20110016546A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Porcine genome editing with zinc finger nucleases
EP3992281A4 (en) * 2019-06-27 2023-07-26 Bionoxx Inc. ONCOLYTIC VIRUS WITH IMPROVED SAFETY AND ANTICANCER EFFECT

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10503641A (ja) 1994-05-02 1998-04-07 ユニバーシティ オブ ワシントン チミジンキナーゼ変異体

Also Published As

Publication number Publication date
NO983449D0 (no) 1998-07-27
US20020102247A1 (en) 2002-08-01
HUP9902571A2 (hu) 1999-11-29
EP0879288A1 (fr) 1998-11-25
BR9707483A (pt) 1999-04-06
US6207150B1 (en) 2001-03-27
IL125597A0 (en) 1999-03-12
SK107998A3 (en) 1999-01-11
AU720936B2 (en) 2000-06-15
KR19990082124A (ko) 1999-11-15
WO1997029196A1 (fr) 1997-08-14
HUP9902571A3 (en) 2002-01-28
CZ247998A3 (cs) 1998-11-11
CZ294497B6 (cs) 2005-01-12
AU1606897A (en) 1997-08-28
JP2000505288A (ja) 2000-05-09

Similar Documents

Publication Publication Date Title
NO983449D0 (no) Varianter av thymidinkinase, tilsvarende nukleinsyresekvenser og deres anvendelse ved genterapi
NO973838D0 (no) DNA-molekyler, deres fremstilling samt anvendelse ved genterapi
AU3199699A (en) Modified nucleotides and methods useful for nucleic acid sequencing
FI960469A (fi) DNA:ta sekvenssoivia entsyymejä
NO994009D0 (no) Gensekvensator og metoder
IL142178A0 (en) Methods of nucleic acid amplification and sequencing
IL139093A0 (en) Optimization of pest resistance genes using dna shuffling
DE69938554D1 (de) Elongase gene und ihre verwendung
AP2000001812A0 (en) Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems
AU7614696A (en) Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
DK1083934T3 (da) Genterapifremgangsmåder
EP1581614A4 (en) NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USING THE SAME
EP1581614A3 (en) Nucleotide sequences for gene regulation and methods of use thereof
DK1108037T3 (da) Nukleinsyremolekyler, der koder for enzymer med fructosyltransferaseaktivitet, og deres anvendelse
AU4425397A (en) Antisense gene therapy for rna viruses
AU6795201A (en) Nucleic acid sequences and methods for the modification of plant gene expression
WO2000061729A3 (en) Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
ZA971086B (en) New thymidine kinase variants, corresponding nucleic acid sequences and their use in gene therapy.
NO975409L (no) <Delta>P62, varianter derav, nukleinsekvenser og deres anvendelse
NO20021713L (no) Selv-kuttende RNA-sekvenser og deres anvendelse for kontroll av proteinsyntese
FR2751988B1 (fr) Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
AU2001263160A1 (en) Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution
AU1928801A (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU2002241409A1 (en) Metylococcus capsulatus genes and dna array for the determination of gene expression in metylococcus capsulatus
DK0862419T3 (da) Mikroindkapslet DNA til vaccination og genterapi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application